Prot# NV20234: A Double-Blind, Randomized, Stratified, Multi-Center Trial Evaluating Conventional and High Dose Oseltamivir in the Treatment of Immunocompromised Patients with Influenza

Project: Research project

Project Details

StatusFinished
Effective start/end date10/25/0711/30/12

Funding

  • Quintiles, Inc. (NV20234)
  • Hoffman-La Roche, Inc. (NV20234)